Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow
August 02, 2023 16:30 ET
|
Profound Medical Corp.
TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases
June 02, 2023 13:40 ET
|
Profound Medical Corp.
TORONTO, June 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Upcoming Investor Events
May 30, 2023 08:00 ET
|
Profound Medical Corp.
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference
May 18, 2023 08:00 ET
|
Profound Medical Corp.
TORONTO, May 18, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Annual and Special Meeting of Shareholders Voting Results
May 17, 2023 16:15 ET
|
Profound Medical Corp.
TORONTO, May 17, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual and Special Meeting...
Profound Medical Announces First Quarter 2023 Financial Results
May 10, 2023 16:05 ET
|
Profound Medical Corp.
TORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting
May 01, 2023 16:30 ET
|
Profound Medical Corp.
– Presentations reinforce the safety, efficacy and durability of the TULSA procedure, further supporting its potential as a mainstream, whole gland or focal treatment for prostate disease – – FARP...
Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow
April 19, 2023 16:30 ET
|
Profound Medical Corp.
TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 19, 2023 16:15 ET
|
Profound Medical Corp.
TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results
March 07, 2023 16:05 ET
|
Profound Medical Corp.
TORONTO, March 07, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...